Derek Overstreet Email & Phone Number

Tempe, Arizona, United States

- Raised over $4 million in non-dilutive funding , including five NIH small business grants as PI.- Designed and directed preclinical development programs on novel extended-release formulations for improved prevention of surgical site infection and 72+ hr treatment of postoperative pain, including elucidation of drug delivery goals in each indication and development of novel formulations to meet those goals.- Authored multiple patent applications on extended-release gel platform… Show more - Raised over $4 million in non-dilutive funding , including five NIH small business grants as PI.- Designed and directed preclinical development programs on novel extended-release formulations for improved prevention of surgical site infection and 72+ hr treatment of postoperative pain, including elucidation of drug delivery goals in each indication and development of novel formulations to meet those goals.- Authored multiple patent applications on extended-release gel platform technology (including three currently awarded patents) Show less

Phoenix, Arizona, United States

- Developed three-dimensional polymer scaffolds for fast cell recovery to enable high-throughput characterization of glioma cell populations depending on their tendency to migrate.- Developed stable, hyaluronic acid-based scaffolds to be used in a new cancer cell invasion assay.- Designed thermoreversible gels with fast dissolution time for easy and efficient cell recovery.

Tempe, Az

- Designed, synthesized, and characterized a novel class of injectable, temperature-responsive hydrogels with controlled swelling and drug release that is nearly independent of gelation temperature.- Developed degradable, in situ forming hydrogels with sustained delivery of antibiotics for treatment of prosthetic joint infection in collaboration with the Orthopaedic Residency at Banner Good Samaritan Medical Center.- Developed in situ crosslinking injectable hydrogels for intracranial… Show more - Designed, synthesized, and characterized a novel class of injectable, temperature-responsive hydrogels with controlled swelling and drug release that is nearly independent of gelation temperature.- Developed degradable, in situ forming hydrogels with sustained delivery of antibiotics for treatment of prosthetic joint infection in collaboration with the Orthopaedic Residency at Banner Good Samaritan Medical Center.- Developed in situ crosslinking injectable hydrogels for intracranial aneurysm embolization.- Mentored several undergraduate students resulting in successful completion of research projects. Show less

Cleveland, Oh

- Synthesized and characterized modified antibiotics for use with refillable, affinity-based drug delivery devices based on complexation with beta-cyclodextrin.

Ph.D., Bioengineering

Bse, Biomedical Engineering

Activities and Societies: Theta Chi Fraternity, Tau Beta Pi Engineering Honor Society Summa Cum Laude Graduation Honors